Analysts forecast 'Revenue- Product- Multiple Sclerosis (MS)- Fumarate- TECFIDERA- Rest of world' to reach $181.80 million. The estimate points to a change of +0.7% from the year-ago quarter.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback